BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.64% | 16.58% | -3.48% | 20.75% | -0.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.64% | 16.58% | -3.48% | 20.75% | -0.73% |
| Cost of Revenue | 12.83% | 22.52% | -8.24% | 44.73% | 3.49% |
| Gross Profit | 19.41% | 14.49% | -1.62% | 13.05% | -2.19% |
| SG&A Expenses | 32.36% | 43.39% | 10.11% | 22.38% | 13.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.51% | 32.80% | -0.20% | 29.31% | 34.76% |
| Operating Income | 113.29% | -11.32% | -9.48% | 0.73% | -59.81% |
| Income Before Tax | 98.83% | -14.42% | -35.34% | 16.77% | -61.93% |
| Income Tax Expenses | 105.08% | -21.58% | -33.35% | 6.73% | -59.40% |
| Earnings from Continuing Operations | 97.06% | -12.37% | -35.86% | 19.88% | -62.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.06% | -12.37% | -35.86% | 19.88% | -62.59% |
| EBIT | 113.29% | -11.32% | -9.48% | 0.73% | -59.81% |
| EBITDA | 1.44% | -10.37% | -8.86% | 0.77% | -13.54% |
| EPS Basic | 96.84% | -12.55% | -36.00% | 19.78% | -62.58% |
| Normalized Basic EPS | 95.86% | -14.53% | -34.82% | 11.09% | -60.49% |
| EPS Diluted | 97.40% | -12.55% | -36.18% | 19.62% | -62.80% |
| Normalized Diluted EPS | 95.86% | -14.53% | -34.82% | 11.09% | -60.49% |
| Average Basic Shares Outstanding | 0.09% | 0.18% | 0.18% | 0.18% | 0.09% |
| Average Diluted Shares Outstanding | 0.08% | 0.16% | 0.17% | 0.18% | 0.10% |
| Dividend Per Share | -- | -- | -- | 1.18% | -- |
| Payout Ratio | -- | 0.27% | -- | -- | -- |